Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Public ClinicalTrials.gov record NCT07220759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity and Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participant will either get cagrilintide or placebo. Which treatment participant get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. For each participant, the study will last for about 1 year and 6 months.
Study identification
- NCT ID
- NCT07220759
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 4, 2025
- Primary completion
- May 11, 2027
- Completion
- Jun 29, 2027
- Last update posted
- Sep 3, 2026
2025 – 2027
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama_Birmingham | Birmingham | Alabama | 35294 | — |
| Chambliss Clinical Trials, LLC | Montgomery | Alabama | 36106 | — |
| Noble Clinical Research | Tucson | Arizona | 85704 | — |
| Scripps Whittier Diabetes Inst | La Jolla | California | 92037 | — |
| Headlands Research CTR Lincoln | Lincoln | California | 95648 | — |
| Pacific Clinical Studies | Los Alamitos | California | 90720 | — |
| Walgreens - Store 4442 | Kissimmee | Florida | 34746 | — |
| Optimal Research Sites | Orange City | Florida | 32763 | — |
| Center for Diab,Obes & Metab | Pembroke Pines | Florida | 33024 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| East West Med Res Inst | Honolulu | Hawaii | 96814 | — |
| MediSphere Medical RC | Evansville | Indiana | 47714 | — |
| Walgreens - Store 3915 | Las Vegas | Nevada | 89146 | — |
| Chear Center LLC | The Bronx | New York | 10455 | — |
| Centricity Res New Bern Multispeciality | New Bern | North Carolina | 28562 | — |
| Accellacare | Wilmington | North Carolina | 28401 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| Holston Medical Group_Bristol | Bristol | Tennessee | 37620 | — |
| Velocity Clinical Res-Dallas | Dallas | Texas | 75230 | — |
| TPMG Clinical Research | Newport News | Virginia | 23606 | — |
| National Clin Res Inc. | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07220759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07220759 live on ClinicalTrials.gov.